Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
ALXN > SEC Filings for ALXN > Form 8-K on 7-May-2014All Recent SEC Filings

Show all filings for ALEXION PHARMACEUTICALS INC

Form 8-K for ALEXION PHARMACEUTICALS INC


7-May-2014

Submission of Matters to a Vote of Security Holders


Item 5.07 Submission of Matters to a Vote of Security Holders.

Alexion Pharmaceuticals, Inc. held its Annual Meeting of Shareholders on May 5, 2014 in New Haven, Connecticut. The results of the matters voted on by the shareholders are set forth below.

1. The election of directors:

                   Votes For                                Abstentions    Broker
                                Votes Against or Withheld                 Non-Votes

Max Link          168,235,753            210,549             2,862,836    7,797,214
Leonard Bell      169,311,315            27,037              1,970,786    7,797,214
William R. Keller 167,960,262           1,627,939            1,720,937    7,797,214
John T. Mollen    170,991,273            25,706               292,159     7,797,214
R. Douglas Norby  166,950,241           1,883,117            2,475,780    7,797,214
Alvin S. Parven   160,539,189           5,081,881            5,688,068    7,797,214
Andreas Rummelt   169,588,445            34,450              1,686,243    7,797,214
Ann M. Veneman    168,014,717           1,608,086            1,686,335    7,797,214

2. The non-binding advisory vote to approve the compensation paid to Alexion's named executive officers as described in Alexion's 2014 proxy statement:

Votes For Votes Against Abstentions Broker Non-Votes

169,768,073 1,306,664 234,401 7,797,214

3. Ratification of the appointment of PricewaterhouseCoopers LLP as Alexion's independent registered public accounting firm:

Votes For Votes Against Abstentions

178,363,991 586,348 156,013

4. Shareholder proposal requesting the Board of Directors to adopt a rule to redeem any current or future shareholder rights plan, or amendment thereto, unless such plan is submitted to a shareholder vote within 12 months:

Votes For Votes Against Abstentions Broker Non-Votes

156,364,027 13,846,822 1,098,289 7,797,214


Signature Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: May 7, 2014 ALEXION PHARMACEUTICALS, INC.

By: /s/ Michael V. Greco
Name: Michael V. Greco
Title: Vice President of Law and Corporate Secretary

  Add ALXN to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for ALXN - All Recent SEC Filings
Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.